-
1
-
-
0032853497
-
Is everything all right if nothing seems wrong? A simple method of assessing the diagnostic value of endoscopic procedures when a gold standard is absent
-
DOI 10.1016/S0022-5347(01)61605-7
-
Schneeweiss S, Kriegmair M, Stepp H,. Is everything all right if nothing seems wrong? A simple method of assessing the diagnostic value of endoscopic procedures when a gold standard is absent. J Urol 1999; 161: 1116-9 (Pubitemid 29426098)
-
(1999)
Journal of Urology
, vol.161
, Issue.4
, pp. 1116-1119
-
-
Schneeweiss, S.1
Kriegmair, M.2
Stepp, H.3
-
2
-
-
0035462031
-
Rapid communication diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms
-
Jeon SS, Kang I, Hong JH, Choi HY, Chai SE,. Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms. J Endourol 2001; 15: 753-9 (Pubitemid 32954388)
-
(2001)
Journal of Endourology
, vol.15
, Issue.7
, pp. 753-759
-
-
Jeon, S.S.1
Kang, I.2
Hong, J.H.3
Choi, H.Y.4
Chai, S.E.5
-
3
-
-
84855813191
-
The value of bladder and prostatic urethra biopsies for detection of carcinoma in situ
-
(in press)
-
Gudjõnsson S, Bläckberg M, Chebil G, et al,. The value of bladder and prostatic urethra biopsies for detection of carcinoma in situ. BJU Int (in press)
-
BJU Int
-
-
Gudjõnsson, S.1
Bläckberg, M.2
Chebil, G.3
-
4
-
-
79955653866
-
Diagnosis of intraurothelial neoplasia: Interobserver variation and the value of individual histopathological attributes
-
Isfoss BL, Majak B, Busch C, Braathen GJ,. Diagnosis of intraurothelial neoplasia: interobserver variation and the value of individual histopathological attributes. Anal Quant Cytol Histol 2011; 33: 75-8
-
(2011)
Anal Quant Cytol Histol
, vol.33
, pp. 75-78
-
-
Isfoss, B.L.1
Majak, B.2
Busch, C.3
Braathen, G.J.4
-
5
-
-
78651059180
-
Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy
-
Melicow MM,. Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol 1952; 68: 261-79
-
(1952)
J Urol
, vol.68
, pp. 261-279
-
-
Melicow, M.M.1
-
6
-
-
76549169587
-
Natural history and clinical behavious of in situ carcinoma of the human urinary bladder
-
Melamed MR, Voutsa NG, Grabstald H,. Natural history and clinical behavious of in situ carcinoma of the human urinary bladder. Cancer 1964; 17: 1533-45
-
(1964)
Cancer
, vol.17
, pp. 1533-1545
-
-
Melamed, M.R.1
Voutsa, N.G.2
Grabstald, H.3
-
7
-
-
0015964410
-
Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladdes
-
Koss LG, Tiamson EM, Robbins MA,. Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladdes. JAMA 1974; 227: 281-6
-
(1974)
JAMA
, vol.227
, pp. 281-286
-
-
Koss, L.G.1
Tiamson, E.M.2
Robbins, M.A.3
-
8
-
-
0017353522
-
Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders. Further studies of surgically removed bladders by mapping
-
Koss LG, Nakanishi I, Freed SZ,. Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping. Urology 1977; 9: 442-55 (Pubitemid 8068947)
-
(1977)
Urology
, vol.9
, Issue.4
, pp. 442-455
-
-
Koss, L.G.1
Nakanishi, I.2
Freed, S.Z.3
-
9
-
-
0019954069
-
The origin of invasive carcinoma of the bladder
-
DOI 10.1002/1097-0142(19820801)50:3<515::AID-CNCR2820500323>3.0. CO;2-Q
-
Brawn PN,. The origin of invasive carcinoma of the bladder. Cancer 1982; 50: 515-9 (Pubitemid 12097422)
-
(1982)
Cancer
, vol.50
, Issue.3
, pp. 515-519
-
-
Brawn, P.N.1
-
10
-
-
0022136447
-
Review of Mayo Clinic experience with carcinoma in situ
-
(Suppl.)
-
Zincke H, Utz DC, Farrow GM,. Review of Mayo Clinic experience with carcinoma in situ. Urology 1985; 26 (Suppl.): 39-46
-
(1985)
Urology
, vol.26
, pp. 39-46
-
-
Zincke, H.1
Utz, D.C.2
Farrow, G.M.3
-
11
-
-
0014052487
-
Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy
-
Bush IM, Whitmore WF Jr,. Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy. J Med Soc N J 1967; 64: 56-60
-
(1967)
J Med Soc N J
, vol.64
, pp. 56-60
-
-
Bush, I.M.1
Whitmore, Jr.W.F.2
-
12
-
-
0014736584
-
The plight of the patient with carcinoma in situ of the bladder
-
Utz DC, Hanash KA, Farrow GM,. The plight of the patient with carcinoma in situ of the bladder. J Urol 1970; 103: 160-4
-
(1970)
J Urol
, vol.103
, pp. 160-164
-
-
Utz, D.C.1
Hanash, K.A.2
Farrow, G.M.3
-
13
-
-
0029656086
-
Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
-
Kriegmair M, Baumgartner R, Knüchel R, Stepp H, Hofstädter F, Hofstetter A,. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996; 155: 105-9
-
(1996)
J Urol
, vol.155
, pp. 105-109
-
-
Kriegmair, M.1
Baumgartner, R.2
Knüchel, R.3
Stepp, H.4
Hofstädter, F.5
Hofstetter, A.6
-
14
-
-
0037881525
-
Gene discovery in bladder cancer progression using cDNA microarrays
-
Sanchez-Carbayo M, Socci ND, Lozano JJ, et al,. Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol 2003; 163: 505-16 (Pubitemid 36909413)
-
(2003)
American Journal of Pathology
, vol.163
, Issue.2
, pp. 505-516
-
-
Sanchez-Carbayo, M.1
Socci, N.D.2
Lozano, J.J.3
Li, W.4
Charytonowicz, E.5
Belbin, T.J.6
Prystowsky, M.B.7
Ortiz, A.R.8
Childs, G.9
Cordon-Cardo, C.10
-
15
-
-
70249110104
-
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development
-
Zieger K, Marcussen N, Borre M, Ørntoft TF, Dyrskjøt L,. Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development. Int J Cancer 2009; 125: 2095-103
-
(2009)
Int J Cancer
, vol.125
, pp. 2095-2103
-
-
Zieger, K.1
Marcussen, N.2
Borre, M.3
Ørntoft, T.F.4
Dyrskjøt, L.5
-
16
-
-
78651277534
-
A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression
-
Vallot C, Stransky N, Bernard-Pierrot I, et al,. A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progression. J Natl Cancer Inst 2011; 103: 47-60
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 47-60
-
-
Vallot, C.1
Stransky, N.2
Bernard-Pierrot, I.3
-
17
-
-
0027240177
-
Genetic alterations in bladder cancer
-
DOI 10.1016/0140-6736(93)91595-D
-
Dalbagni G, Presti J, Reuter V, Fair WR, Cordon-Cardo C,. Genetic alterations in bladder cancer. Lancet 1993; 342: 469-71 (Pubitemid 23240312)
-
(1993)
Lancet
, vol.342
, Issue.8869
, pp. 469-471
-
-
Dalbagni, G.1
Presti, J.2
Reuter, V.3
Fair, W.R.4
Cordon-Cardo, C.5
-
18
-
-
0033896830
-
Genetic and Epigenetic Alterations in Normal Bladder Epithelium in Patients with Metachronous Bladder Cancer
-
Muto S, Horie S, Takahashi S,. Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer. Cancer Res 2000; 60: 4021-5 (Pubitemid 30636576)
-
(2000)
Cancer Research
, vol.60
, Issue.15
, pp. 4021-4025
-
-
Muto, S.1
Horie, S.2
Takahashi, S.3
Tomita, K.4
Kitamura, T.5
-
19
-
-
2542565666
-
Gene expression in the urinary bladder: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
-
DOI 10.1158/0008-5472.CAN-03-3620
-
Dyrskjøt L, Kruhøffer M, Thykjaer T, et al,. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 2004; 64: 4040-8 (Pubitemid 38697320)
-
(2004)
Cancer Research
, vol.64
, Issue.11
, pp. 4040-4048
-
-
Dyrskjot, L.1
Kruhoffer, M.2
Thykjaer, T.3
Marcussen, N.4
Jensen, J.L.5
Moller, K.6
Orntoft, T.F.7
-
20
-
-
0028183081
-
Natural history of carcinoma in situ of the urinary bladder
-
Wolf H, Melsen F, Pedersen SE, Nielsen KT,. Natural history of carcinoma in situ of the urinary bladder. Scand J Urol Nephrol 1994; 157 (Suppl.): 147-51 (Pubitemid 24205663)
-
(1994)
Scandinavian Journal of Urology and Nephrology, Supplement
, Issue.157
, pp. 147-151
-
-
Wolf, H.1
Melsen, F.2
Pedersen, S.E.3
Nielsen, K.T.4
-
21
-
-
32944465832
-
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC Risk Tables: A combined analysis of 2596 patients from seven EORTC trials
-
Sylvester RJ, van der Mejden AP, Oosterlinck W, et al,. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC Risk Tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-77
-
(2006)
Eur Urol
, vol.49
, pp. 466-477
-
-
Sylvester, R.J.1
Van Der Mejden, A.P.2
Oosterlinck, W.3
-
22
-
-
33751407204
-
Concomitant Carcinoma In Situ Is a Feature of Aggressive Disease in Patients With Organ-Confined TCC at Radical Cystectomy
-
DOI 10.1016/j.eururo.2006.08.037, PII S0302283806010013
-
Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, et al,. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-defined TCC at radical cystectomy. Eur Urol 2007; 51: 152-60 (Pubitemid 44821530)
-
(2007)
European Urology
, vol.51
, Issue.1
, pp. 152-160
-
-
Shariat, S.F.1
Palapattu, G.S.2
Karakiewicz, P.I.3
Rogers, C.G.4
Vazina, A.5
Bastian, P.J.6
Schoenberg, M.P.7
Lerner, S.P.8
Sagalowsky, A.I.9
Lotan, Y.10
-
23
-
-
76749162310
-
Diagnostic random biopsies: Reflections from a population-based cohort of 538 patients
-
Thorstenson A, Schumacher MC, Wiklund NP, et al,. Diagnostic random biopsies: reflections from a population-based cohort of 538 patients. Scand J Urol Nephrol 2010; 44: 11-9
-
(2010)
Scand J Urol Nephrol
, vol.44
, pp. 11-19
-
-
Thorstenson, A.1
Schumacher, M.C.2
Wiklund, N.P.3
-
24
-
-
0033427043
-
Fluorescence detection of bladder tumors with 5-amino-levulinic acid
-
Riedl CR, Plas E, Pflüger H,. Fluorescence detection of bladder tumors with 5-aminolevulinic acid. J Endourol 1999; 13: 755-9 (Pubitemid 30036486)
-
(1999)
Journal of Endourology
, vol.13
, Issue.10
, pp. 755-759
-
-
Riedl, C.R.1
Plas, E.2
Pfluger, H.3
-
25
-
-
0037907247
-
Detection of bladder dysplasia using 5-aminolaevulinic acid-induced porphyrin fluorescence
-
DOI 10.1046/j.1464-410X.2003.04182.x
-
Landry JL, Gelet A, Bouvier R, Dubernard JM, Martin X, Colombel M,. Detection of bladder dysplasia using 5-minolaevulinic acid-induced porphyrin fluorescence. BJU Int 2003; 91: 623-6 (Pubitemid 36583731)
-
(2003)
BJU International
, vol.91
, Issue.7
, pp. 623-626
-
-
Landry, J.L.1
Gelet, A.2
Bouvier, R.3
Dubernard, J.M.4
Martin, X.5
Colombel, M.6
-
26
-
-
0038650878
-
Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy
-
DOI 10.1016/S0302-2838(03)00210-0
-
Grimbergen MC, van Swol CF, Jonges TG, Boon TA, van Moorselaar RJ,. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol 2003; 44: 51-6 (Pubitemid 36741375)
-
(2003)
European Urology
, vol.44
, Issue.1
, pp. 51-56
-
-
Grimbergen, M.C.M.1
Van Swol, C.F.P.2
Jonges, T.G.N.3
Boon, T.A.4
Van Moorselaar, R.J.A.5
-
27
-
-
70349469584
-
Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: Identification of patient groups that may benefit most from highly specific optical diagnostics
-
Draga RO, Grimbergen MC, Kok ET, Jonges TN, Bosch JL,. Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: identification of patient groups that may benefit most from highly specific optical diagnostics. Urology 2009; 74: 851-7
-
(2009)
Urology
, vol.74
, pp. 851-857
-
-
Draga, R.O.1
Grimbergen, M.C.2
Kok, E.T.3
Jonges, T.N.4
Bosch, J.L.5
-
28
-
-
0038679302
-
Hexyl aminolevulinate fluorescence cystoscopy: A new diagnostic tool for the photodiagnosis of superficial bladder cancer - A multicenter study
-
DOI 10.1097/01.ju.0000060782.52358.04
-
Jichlinski P, Guillou L, Karlsen SJ, et al,. Hexylaminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer-a multicenter study. J Urol 2003; 170: 226-9 (Pubitemid 36734467)
-
(2003)
Journal of Urology
, vol.170
, Issue.1
, pp. 226-229
-
-
Jichlinski, P.1
Guillou, L.2
Karlsen, S.J.3
Malmstrom, P.-U.4
Jocham, D.5
Brennhovd, B.6
Johansson, E.7
Gartner, T.8
Lange, N.9
Van Den Bergh, H.10
Leisinger, H.-J.11
-
29
-
-
0346848832
-
Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy
-
DOI 10.1097/01.ju.0000100480.70769.0e
-
Schmidbauer J, Witjes F, Schmeller N, et al,. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004; 171: 135-8 (Pubitemid 37549108)
-
(2004)
Journal of Urology
, vol.171
, Issue.1
, pp. 135-138
-
-
Schmidbauer, J.1
Witjes, F.2
Schmeller, N.3
Donat, R.4
Susani, M.5
Marberger, M.6
-
30
-
-
13844272458
-
Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: A new approach for bladder cancer detection and surveillance?
-
DOI 10.1016/j.eururo.2004.10.025
-
Loidl W, Schmidbauer J, Susani M, Marberger M,. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 2005; 47: 323-6 (Pubitemid 40248853)
-
(2005)
European Urology
, vol.47
, Issue.3
, pp. 323-326
-
-
Loidl, W.1
Schmidbauer, J.2
Susani, M.3
Marberger, M.4
-
31
-
-
23744483075
-
Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: A prospective, phase III multicenter study
-
DOI 10.1097/01.ju.0000169257.19841.2a
-
Jocham D, Witjes F, Wagner S, et al,. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 2005; 174: 862-6 (Pubitemid 41140613)
-
(2005)
Journal of Urology
, vol.174
, Issue.3
, pp. 862-866
-
-
Jocham, D.1
Witjes, F.2
Wagner, S.3
Zeylemaker, B.4
Van Moorselaar, J.5
Grimm, M.-O.6
Muschter, R.7
Popken, G.8
Konig, F.9
Knuchel, R.10
Kurth, K.-H.11
-
32
-
-
34250304337
-
A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study
-
DOI 10.1016/j.juro.2007.03.028, PII S0022534707005368
-
Fradet Y, Grossman HB, Gomella L, et al,. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol 2007; 178: 68-73 (Pubitemid 46908730)
-
(2007)
Journal of Urology
, vol.178
, Issue.1
, pp. 68-73
-
-
Fradet, Y.1
Grossman, H.B.2
Gomella, L.3
Lerner, S.4
Cookson, M.5
Albala, D.6
Droller, M.J.7
-
33
-
-
78549267752
-
HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer - Re-TURBT recurrence rates in a prospective, randomized study
-
Geavlete B, Jecu M, Multescu R, Georgescu D, Geavlete P,. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer-re-TURBT recurrence rates in a prospective, randomized study. Urology 2010; 76: 664-9
-
(2010)
Urology
, vol.76
, pp. 664-669
-
-
Geavlete, B.1
Jecu, M.2
Multescu, R.3
Georgescu, D.4
Geavlete, P.5
-
34
-
-
0032992931
-
Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid
-
DOI 10.1046/j.1464-410X.1999.00917.x
-
Koenig F, McGovern FJ, Larne R, Enquist H, Schomacker KT, Deutsch TF,. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int 1999; 83: 129-35 (Pubitemid 29151420)
-
(1999)
BJU International
, vol.83
, Issue.1
, pp. 129-135
-
-
Koenig, F.1
McGovern, F.J.2
Larne, R.3
Enquist, H.4
Schomacker, K.T.5
Deutsch, T.F.6
-
35
-
-
0032588751
-
Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid
-
Filbeck T, Roessler W, Knuechel R, Straub M, Kiel HJ, Wieland WF,. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid. J Endourol 1999; 13: 117-21 (Pubitemid 29176696)
-
(1999)
Journal of Endourology
, vol.13
, Issue.2
, pp. 117-121
-
-
Filbeck, T.1
Roessler, W.2
Knuechel, R.3
Straub, M.4
Kiel, H.J.5
Wieland, W.F.6
-
36
-
-
0033916017
-
Cystoscopic diagnosis of bladder cancer by intravesical instillation of 5-aminolevulinic acid induced porphyrin fluorescence - The Singapore experience
-
Cheng CW, Lau WK, Tan PH, Olivo M,. Cystoscopic diagnosis of bladder cancer by intravesical instillation of 5-aminolevulinic acid induced porphyrin fluorescence-the Singapore experience. Ann Acad Med Singapore 2000; 29: 153-8 (Pubitemid 30434428)
-
(2000)
Annals of the Academy of Medicine Singapore
, vol.29
, Issue.2
, pp. 153-158
-
-
Cheng, C.W.S.1
Lau, W.K.O.2
Tan, P.H.3
Olivo, M.4
-
37
-
-
2342632006
-
The photodynamic diagnosis (FLC) for early detection of carcinoma and dysplasia of the bladder
-
Zumbraegel A, Bichler KH, Krause FS, Feil G, Nelde HJ,. The photodynamic diagnosis (FLC) for early detection of carcinoma and dysplasia of the bladder. Adv Exp Med Biol 2003; 539: 61-6
-
(2003)
Adv Exp Med Biol
, vol.539
, pp. 61-66
-
-
Zumbraegel, A.1
Bichler, K.H.2
Krause, F.S.3
Feil, G.4
Nelde, H.J.5
-
38
-
-
76649099556
-
Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
-
Mowatt G, Zhu S, Kilonzo M, et al,. Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. Health Technol Assess 2010; 14: 1-356
-
(2010)
Health Technol Assess
, vol.14
, pp. 1-356
-
-
Mowatt, G.1
Zhu, S.2
Kilonzo, M.3
-
39
-
-
77249090657
-
Photodynamic diagnosis in non-muscle-invasive bladder cancer: A systematic review and cumulative analysis of prostpective studies
-
Kausch I, Sommerauer M, Montorsi F, et al,. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prostpective studies. Eur Urol 2010; 57: 595-606
-
(2010)
Eur Urol
, vol.57
, pp. 595-606
-
-
Kausch, I.1
Sommerauer, M.2
Montorsi, F.3
-
40
-
-
70849130933
-
Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors
-
Burger M, Stief CG, Zaak D, et al,. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors. Urology 2009; 74: 1282-6
-
(2009)
Urology
, vol.74
, pp. 1282-1286
-
-
Burger, M.1
Stief, C.G.2
Zaak, D.3
|